O5 - Single centre audit of implementation of a care pathway in penile cancer

Publication date: November 2018Source: European Urology Supplements, Volume 17, Issue 14Author(s): J. Vanthoor, U. Milenkovic, W. Everaerts, H. Van Poppel, G. De Meerleer, H. Dumez, K. Goffin, E. Vanhoutte, A. Van Rompuy, S. Joniau, M. Albersen
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research

Related Links:

ConclusionPatients with PeCa are best treated by experienced physicians, in centers with a high number of cases, which also offer a wide range of local tumor therapy. This could be offered in reference centers.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
CONCLUSION: The use of oncological treatment was below recommendations in guidelines but increased during the study period. Treatment was given predominantly to men with c/pN2-3 and M1-disease. Survival was higher among men treated with curative intent; this could be due to patient selection bias. PMID: 33030399 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Tags: Acta Oncol Source Type: research
We examined the importance of sarcopenia as a predictive marker of the prognosis in penile cancer. MATERIALS AND METHODS: A total of 25 patients diagnosed with penile cancer who underwent penile resection from 2000 to 2010 were analyzed in this study. The psoas muscle index (PMI) was calculated based on psoas area using preoperative axial computed tomography images at the right L3 level divided by the square of the body height. RESULTS: Nineteen (76.0%) patients underwent partial penectomy, and 6 (24.0%) underwent total penectomy. The median (mean ± standard deviation) age was 69.3 (69.0 ± 10.1) years...
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
Publication date: Available online 3 October 2020Source: European UrologyAuthor(s): Ahmet Murat Aydin, Nicholas H. Chakiryan, Philippe E. Spiess
Source: European Urology - Category: Urology & Nephrology Source Type: research
Conditions:   Head and Neck Cancer;   Penile Cancer Intervention:   Sponsor:   The Netherlands Cancer Institute Suspended
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
la AL Abstract The majority of penile malignant tumors are squamous cell carcinomas. They are pathologically defined as epithelial neoplasms originating in the squamous cells of the inner mucosal lining of the glans, coronal sulcus or foreskin. Tumor location and site of origin is preferentially in glans (70%) followed by foreskin (25%) and coronal sulcus (5%). Despite the variable geographic distribution, pathological features of penile carcinomas in areas of high- and low-risk are similar. Penile tumors are morphologically heterogeneous. A major advance, based on biological, etiological and prognostic factors, i...
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Tags: Urol Oncol Source Type: research
CONCLUSION: We detected significant contouring IOV in routine practice using easily accessible retrospective data and successfully decreased IOV in our clinic through a reflective intervention. Continued application of this approach may aid improvements in practice standardization and enhance quality of care. PMID: 32988249 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Tags: Acta Oncol Source Type: research
This study describes the epidemiological, histopathological and clinical profile of patients stricken across that Brazilian s...
Source: BMC Research Notes - Category: Research Authors: Tags: Data note Source Type: research
Publication date: Available online 17 September 2020Source: European UrologyAuthor(s): Paolo Dell’Oglio, Hielke M. de Vries, Elio Mazzone, Gijs H. KleinJan, Maarten L. Donswijk, Henk G. van der Poel, Simon Horenblas, Fijs W.B. van Leeuwen, Oscar R. Brouwer
Source: European Urology - Category: Urology & Nephrology Source Type: research
Abstract Human papillomavirus (HPV) causes most cervical cancers and some cancers of the penis, vulva, vagina, oropharynx, and anus. Cervical precancers can be detected through screening. HPV vaccination with the 9-valent HPV vaccine (9vHPV) can prevent approximately 92% of HPV-attributable cancers (1).* Previous studies have shown lower incidence of HPV-associated cancers in non-Hispanic American Indian and Alaska Native (AI/AN) populations compared with other racial subgroups (2); however, these rates might have been underestimated as a result of racial misclassification. Previous studies have shown that cancer ...
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Tags: MMWR Morb Mortal Wkly Rep Source Type: research
More News: Cancer | Cancer & Oncology | Penile Cancer | Urology & Nephrology